.gemini-dropdown-panel\:h\>Fill\(\$titleHoverColor\),.reactions:hover .reactions\:h_Fill\(\$titleHoverColor\){fill:#5d5eff!important}.BdY{border-width:1px 0}.Cf:after,.Cf:before{content:" ";display:table}.Cf:after{clear:both}.Ell:after,a[class*=LineClamp]:after{content:".";font-size:0;height:0;width:0}.Ell{hyphens:none;max-width:100%}.Hidden{position:absolute!important;clip:rect(1px,1px,1px,1px);border:0!important;height:1px!important;width:1px!important}[class*=LineClamp]{-webkit-box-orient:vertical}[class*=LineClamp],a[class*=LineClamp]{display:-webkit-box}.LineClamp\(2\,40px\),.LineClamp\(2\,44px\){-webkit-line-clamp:2}.LineClamp\(2\,40px\){max-height:40px}.LineClamp\(2\,44px\){max-height:44px}.LineClamp\(3\,60px\),.LineClamp\(3\,66px\){-webkit-line-clamp:3}.LineClamp\(3\,60px\){max-height:60px}.LineClamp\(3\,66px\){max-height:66px}.LineClamp\(4\,80px\){-webkit-line-clamp:4;max-height:80px}.StretchedBox{bottom:0;left:0;right:0;top:0}@media screen and (max-width:767px){#atomic .Fw\(900\)--xs[class]{font-weight:900}}@media screen and (max-width:959px){#atomic .Fz\(16px\)--sm[class]{font-size:16px}}@media screen and (orientation:landscape){#atomic .D\(n\)--landscape[class]{display:none}}@media screen and (max-width:320px){#atomic .Fz\(13px\)--sm320[class]{font-size:13px}}@media screen and (min-device-height:740px){#atomic .Bgc\(--black\)--mdh740[class]{background-color:#000;background-color:var(--black)}#atomic .Bgc\(--dirty-seagull\)--mdh740[class]{background-color:#e0e4e9;background-color:var(--dirty-seagull)}#atomic .Bgpy\(35\%\)--mdh740[class]{background-position-y:35%}#atomic .H\(177\.77vw\)--mdh740[class]{height:177.77vw}#atomic .H\(smadBigFontXLImgHeight\)\!--mdh740[class]{height:calc(178vw - 20px)!important}#atomic .H\(smadSImgHeight\)\!--mdh740[class]{height:142vw!important}#atomic .H\(smadXLImgHeight\)\!--mdh740[class]{height:calc(177.77vw - 20px)!important}#atomic .T\(smadTop\)--mdh740[class]{top:auto!important}#atomic .B\(40vw\)\!--mdh740[class]{bottom:40vw!important}#atomic .B\(flashSaleXBottom\)\!--mdh740[class]{bottom:calc(50vh - 88.885vw + 41.5px)!important}#atomic .B\(smadBottom\)\!--mdh740[class]{bottom:calc(50vh - 88.885vw - 15.5px)!important}#atomic .B\(smadMuteBottomX\)\!--mdh740[class]{bottom:calc(50vh - 88.885vw)!important}#atomic .B\(smadNoUhBottom\)--mdh740[class]{bottom:calc(50vh - 88.885vw - 5.5px)}}@media screen and (min-device-width:320px) and (max-device-width:375px){#atomic .Fz\(11px\)\!--minw320[class]{font-size:11px!important}#atomic .W\(11\.5px\)\!--minw320[class]{width:11.5px!important}}@media screen and (min-device-width:375px){#atomic .Fz\(13px\)\!--minw375[class]{font-size:13px!important}}
Svoboda | Graniru | BBC Russia | Golosameriki | Facebook
Advertisement

Topic

COVID-19 News & Analysis | Yahoo Canada

Retiree calls out Sask. gov't for not communicating changes to accessing COVID-19 drug Paxlovid

  • A 63-year-old Saskatoon man says he has lost faith in the Saskatchewan government's health-care system, and he may move provinces because of it.A big issue, he says, is that the province does not properly communicate new health-care information with the public. When Greg Pletz contracted COVID-19 in mid-May, he called the Saskatchewan 811 HealthLine and was told to contact his general practitioner for a prescription forPaxlovid, Pfizer's antiviral drug.But that process proved to be far more diff

COVID-19 Around the World

COVID-19 Q&A

What happens if you catch COVID-19 more than once?

A look at the science behind COVID-19 reinfection, including what to expect and who's most at risk.
  • 02:01
  • 01:43
  • 01:32
  • 02:02
  • 02:01
  • 02:56
  • 02:26

Latest News

  • BusinessCBC

    Nunavut tourism industry starting to rebound after COVID-19 pandemic shut it down

    Tourist visits in Nunavut have started to rebound since the end of the COVID-19 pandemic.Figures provided by Parks Canada show that in one park alone, visitation in 2023-24 is at 77 per cent of where it was in the last season before the onset of the pandemic."Last year, we had 253 visitors," said Leanna Ellsworth, manager of Auyuittuq National Park. "Annually, we do get up to 300 visitors."Ellsworth says of all five national parks in Nunavut, Auyuittuq is the most popular one.But it's not just n

    Thanks for your feedback!
  • NewsYahoo News UK

    What is the COVID inquiry and who does the report blame for failings?

    UK 'prepared for the wrong pandemic', COVID inquiry finds.

    Thanks for your feedback!
  • NewsYahoo News UK

    The Tories partied while my dad died during COVID. I'm glad they've been voted out

    Lynda Wardley believes the Conservatives' handling of COVID – and the Partygate scandal in particular – contributed to their heavy election defeat.

    Thanks for your feedback!
  • HealthYahoo News UK

    What you need to do if you get COVID this summer

    Experts are warning we are in the midst of a summer COVID wave as infections are on the rise.

    Thanks for your feedback!
  • HealthCBC

    COVID-19 experts warn of risks of summer surge as N.B. hazard index leads country

    Two infectious disease experts are warning New Brunswickers about the risks of COVID-19 heading into the summer, when they say many people mistakenly believe infections decrease.New Brunswick has the highest COVID-19 risk index in the country right now — more than double the national average, according to Tara Moriarty, an infectious disease researcher and lead of COVID-19 Resources Canada, which produces a weekly forecast.The province is listed as "severe" for June 22 to July 5, with a score of

    Thanks for your feedback!
  • NewsCBC

    Retiree calls out Sask. gov't for not communicating changes to accessing COVID-19 drug Paxlovid

    A 63-year-old Saskatoon man says he has lost faith in the Saskatchewan government's health-care system, and he may move provinces because of it.A big issue, he says, is that the province does not properly communicate new health-care information with the public. When Greg Pletz contracted COVID-19 in mid-May, he called the Saskatchewan 811 HealthLine and was told to contact his general practitioner for a prescription forPaxlovid, Pfizer's antiviral drug.But that process proved to be far more diff

    Thanks for your feedback!
  • NewsThe Canadian Press

    IRS sues Ohio doctor whose views on COVID-19 vaccinations drew complaints

    CLEVELAND (AP) — An Ohio doctor who drew national attention when she claimed COVID-19 vaccines made people magnetic is being sued by the federal government over claims she hasn't paid nearly $650,000 in federal taxes and late fees. The lawsuit, filed last month in federal court in Cleveland, claims Sherri Tenpenny didn't pay taxes in 2001, 2012 and 2013. Tenpenny, an osteopathic doctor, has been licensed in Ohio since 1984. She told Cleveland.com that she's tried to settle the dispute with the s

    Thanks for your feedback!
  • US PoliticsYahoo News

    Fauci testifies before Congress for first time since leaving government: 5 takeaways from the hearing

    The 83-year-old former director of the National Institute of Allergy and Infectious Diseases sought to debunk conservative conspiracy theories about his response to COVID-19.

    Thanks for your feedback!
  • NewsThe Canadian Press

    B.C. government to pay for COVID-19 drug Paxlovid after feds drop coverage

    VICTORIA — British Columbia will cover the cost of an antiviral drug aimed at treating mild to moderate cases of COVID-19 as the federal government ends its coverage. A statement from B.C.'s Health Ministry says the province will provide 100 per cent coverage for the treatment sold under the brand name Paxlovid, for B.C. residents with an active medical services plan. A provincial government web page says the change took effect on Tuesday, after the federal government stopped supplying Paxlovid

    Thanks for your feedback!
  • HealthCBC

    COVID-19 antiviral medication no longer available for free in Nova Scotia

    A costly drug used to treat people who are at risk of becoming severely ill or dying after contracting COVID-19 is no longer available free of charge in Nova Scotia.Paxlovid has been free for eligible patients in Nova Scotia since early 2022, but that has changed now that Ottawa is no longer paying to supply provinces with the antiviral.Michelle Thompson, Nova Scotia's health minister, said Wednesday the antiviral has been added to the list of drugs covered by the province's Pharmacare programs.

    Thanks for your feedback!
Advertisement

More Emerging Topics | News & Updates

View More Emerging Topics | News & Updates
Advertisement